Stay updated on CT-P16 vs Avastin in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the CT-P16 vs Avastin in Lung Cancer Clinical Trial page.

Latest updates to the CT-P16 vs Avastin in Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page footer now displays Revision: v3.3.3, while Revision: v3.3.2 and the HHS Vulnerability Disclosure entry were removed.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedAdded a clarification that PubMed publications are automatically filled from PubMed and may not be about the study, along with a revision note indicating version v3.3.2. The previous PubMed wording and version reference (v3.2.0) were removed.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved the government funding/operating-status notice from the page. The study details and eligibility information remain unchanged.SummaryDifference0.4%

- Check69 days agoChange DetectedThe new screenshot shows only minor layout and styling adjustments with no changes to core study content (design, eligibility criteria, interventions, or outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check98 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference4%

- Check105 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to CT-P16 vs Avastin in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P16 vs Avastin in Lung Cancer Clinical Trial page.